The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
from NYT > Top Stories https://ift.tt/SKHvdEc
No comments:
Post a Comment